Galangal's Antimicrobial and Antifungal Effects

Galangal kills things in a petri dish. It kills a broad and genuinely impressive range of things: food-poisoning bacteria, the fungi that cause ringworm and athlete's foot, Candida including some azole-resistant strains, and organisms carrying multiple antibiotic-resistance genes. One line of research even suggests it interferes with the bacterial plasmids that carry resistance genes from one organism to another, which would be an unusual and useful trick if it held up.

All of that is real laboratory work and none of it means you can treat an infection with a spice. This page explains what has actually been shown, why the gap between a culture plate and a human body is so wide, and where the traditional topical uses sit — because the one place galangal's antimicrobial reputation has a plausible practical foothold is on skin, not inside you.

Table of Contents

  1. The Claim, and the Short Answer
  2. Which Compounds, From Which Species
  3. Two Different Mechanisms
  4. Antibacterial Findings
  5. The Antiplasmid Result
  6. Antifungal Findings and the Ringworm Tradition
  7. Food Preservation: The Most Defensible Use
  8. Why In Vitro Does Not Transfer
  9. Where This Becomes Dangerous
  10. Sensible Use
  11. Key Research Papers
  12. Connections

The Claim, and the Short Answer

The claim is that galangal is a natural antibiotic and antifungal that can be used against infections.

Short answer: the antimicrobial activity is real and well documented at the preliminary (in-vitro) tier. Topical antifungal use has traditional use only status in humans, with in-vitro support. There is no human trial showing that galangal treats any infection — not a skin infection, not a gut infection, not a systemic one. The half of the claim that is defensible is food-related: spice extracts do inhibit spoilage and pathogen growth in food systems, which is a food-science finding, not a medical one.

Which Compounds, From Which Species

Three things in galangal do the antimicrobial work, and they belong to different species in different proportions.

A fourth plant, Kaempferia galanga (kencur), is sold under the same market name and has its own antimicrobial literature driven by ethyl p-methoxycinnamate. It is a different plant, and its data are not galangal's data. See our kencur page.

Two Different Mechanisms

Understanding the difference between these two mechanisms explains most of what follows.

Membrane disruption — powerful, and completely unselective. Terpenes are small, greasy molecules that dissolve into lipid membranes and destabilise them. Enough of them in the membrane and the cell leaks its contents and dies. This works on bacteria, on fungi, and — at high enough concentration — on human cells, which have membranes too. That is why terpene-rich essential oils are excellent surface disinfectants and poor systemic drugs: the concentration that kills the microbe is not comfortably below the concentration that harms you. It is also why "it killed the bacteria in the assay" tells you far less than it sounds like it should.

Targeted molecular action — rarer and more interesting. ACA appears to do something beyond membrane damage, including the antiplasmid effect described below and, in some systems, interference with microbial signalling. A targeted mechanism is what you want in a real drug, because selectivity is what lets you kill the pathogen without killing the patient.

Antibacterial Findings

Evidence tier: preliminary (in vitro) throughout.

Weerakkody and colleagues published "Synergistic antimicrobial activity of galangal (Alpinia galanga), rosemary (Rosmarinus officinalis) and lemon iron bark (Eucalyptus staigerana) extracts" in the Journal of the Science of Food and Agriculture in 2011. The interesting part is the word synergistic: combinations of the three extracts inhibited food-borne bacteria at lower concentrations than any one alone. Synergy between plant antimicrobials is a recurring finding in food science and one of the more scientifically respectable arguments for spice-heavy cuisine as a preservation strategy in hot climates.

Galangal has also appeared in screens against organisms of medical interest. Bhamarapravati, Pendland and Mahady's "Extracts of spice and food plants from Thai traditional medicine inhibit the growth of the human carcinogen Helicobacter pylori," published in In Vivo in 2003, tested Thai culinary and medicinal plants against the stomach bacterium responsible for most peptic ulcers, with several showing inhibition in culture. Later Thai work has examined galangal extracts against the bacteria implicated in acne, reporting activity alongside cytotoxicity data — and the cytotoxicity half of such reports is the half that gets left out of marketing.

What all of it has in common: extract meets microbe directly, in a controlled medium, at a concentration the experimenter chose. Nothing about that situation resembles swallowing a capsule.

The Antiplasmid Result

Evidence tier: preliminary (in vitro), and the most mechanistically interesting result on this page.

Latha and colleagues published "Antiplasmid activity of 1'-acetoxychavicol acetate from Alpinia galanga against multi-drug resistant bacteria" in the Journal of Ethnopharmacology in 2009.

Some background on why that title matters. Bacteria carry most of their genome on one circular chromosome, but many also carry plasmids — small, separate loops of DNA that replicate independently and can be passed between bacteria, including between different species. Plasmids are the main vehicle by which antibiotic resistance spreads: a resistance gene on a plasmid can move from a harmless gut organism into a pathogen in a matter of hours. A compound that cures bacteria of their plasmids — makes them lose these loops during division — would not necessarily kill them, but would strip their resistance and could in principle restore sensitivity to existing antibiotics.

That is what this paper reports for ACA against multi-drug-resistant isolates in the laboratory.

Why this has not become a drug. Plasmid curing has been observed with many compounds since the 1960s and has translated into clinical medicine approximately never. To be useful, the compound must reach the site of infection at an active concentration, act on the resistant organism selectively rather than on the whole gut flora, and do so without toxicity — and it must be paired with an antibiotic in a properly designed trial to demonstrate any benefit. ACA's instability makes each of those harder. The finding is a legitimate lead in the antimicrobial-resistance literature. It is not a reason to take galangal.

Antifungal Findings and the Ringworm Tradition

Evidence tier: traditional use only in humans, with preliminary (in-vitro) support. This is the strongest link between galangal's laboratory profile and something people actually do.

In Malay and Indonesian practice, a cut face of fresh lengkuas rhizome is rubbed directly on ringworm and other fungal skin patches. It is a well-documented folk use, it is specific, and it is topical — which is exactly the setting where a membrane-disrupting plant extract is most likely to do something, because you can apply a high concentration where you want it and nowhere else.

The laboratory work lines up with the tradition. A. galanga extracts inhibit dermatophytes — the Trichophyton, Microsporum and Epidermophyton fungi responsible for ringworm, athlete's foot, jock itch and fungal nail infection — in culture and in veterinary dermatology research. ACA has also been reported active against Candida albicans, including azole-resistant isolates, which is a clinically meaningful category of organism.

What is still missing is any controlled human trial. Nobody has randomised people with confirmed ringworm to galangal versus a standard topical antifungal and measured cure rates and recurrence. Until that exists, the honest description is "traditional use with a plausible chemical basis".

And a practical warning. Fresh rhizome juice on skin is not a controlled preparation. It can irritate, it can sensitise, and it is not sterile. Fungal skin infections are also frequently misdiagnosed by eye — discoid eczema, psoriasis, granuloma annulare and pityriasis rosea are all mistaken for ringworm regularly — and applying an irritant to inflammatory skin disease makes it worse. Modern topical antifungals are cheap, available without prescription in most countries, and have known cure rates. See our pages on ringworm and athlete's foot.

Food Preservation: The Most Defensible Use

Evidence tier: preliminary, but in a setting where in-vitro data actually applies.

There is one context where "galangal inhibits bacteria in a dish" is a directly relevant finding: food. Food is, in effect, a dish. When spice extracts are added to a food matrix and the growth of spoilage organisms and pathogens is measured, the concentrations tested are much closer to reality, and the target is right there in contact with the compound.

This is the strongest scientific version of a familiar cultural observation. Southeast Asian cuisines are among the most heavily spiced in the world, they developed in hot and humid climates before refrigeration, and the spices they use most — galangal, lemongrass, garlic, chilli, turmeric, kaffir lime — are consistently among the more antimicrobial in laboratory screens. Whether that is causal, coincidental, or partly driven by taste and availability is debated, but the food-science data are solid enough to be used in real preservation research.

None of which is a medical claim. A curry paste that resists spoilage a little longer is not a treatment for anything.

Why In Vitro Does Not Transfer

This is the crux of the page, so it is worth being concrete about the barriers between a positive culture-plate result and a treated infection.

The historical record makes the point better than any argument: essentially every antimicrobial plant extract ever screened has shown activity in vitro, and the number that became clinically used antibacterials by that route is vanishingly small. In-vitro activity is the price of entry to drug discovery, not evidence of efficacy.

Where This Becomes Dangerous

This site is generally relaxed about people trying traditional remedies. Infection is the exception, and the reason is timing.

Most bacterial infections that turn serious do so over hours to days. A cellulitis that would have resolved with oral antibiotics on day one can require intravenous treatment on day three. Untreated strep throat carries a small but real risk of rheumatic fever. A urinary tract infection can ascend to the kidneys. Sepsis kills quickly, and survival in sepsis is measured against the clock from the first dose of appropriate antibiotic. Delay is the harm. A remedy that does nothing is not neutral if it occupies the days during which effective treatment should have started.

Specific red flags that mean stop and seek care, not try a spice: spreading redness, especially with a visible advancing edge or red streaking; fever with a skin infection; an infection that worsens over 24 to 48 hours; severe pain out of proportion to appearance; any infection in someone with diabetes, immunosuppression, or a prosthetic joint or valve; infections around the eye or on the face; and any confusion, breathlessness, or rapid heartbeat alongside an infection.

Galangal has no role in any of those situations. Neither does any other spice.

Sensible Use

Key Research Papers

Cited as PubMed searches rather than fixed identifiers, so each link resolves to the paper as indexed today.

  1. Latha and colleagues, "Antiplasmid activity of 1'-acetoxychavicol acetate from Alpinia galanga against multi-drug resistant bacteria," Journal of Ethnopharmacology, 2009. Find on PubMed.
  2. Weerakkody and colleagues, "Synergistic antimicrobial activity of galangal (Alpinia galanga), rosemary (Rosmarinus officinalis) and lemon iron bark (Eucalyptus staigerana) extracts," Journal of the Science of Food and Agriculture, 2011. Find on PubMed.
  3. Bhamarapravati, Pendland and Mahady, "Extracts of spice and food plants from Thai traditional medicine inhibit the growth of the human carcinogen Helicobacter pylori," In Vivo, 2003. Find on PubMed.
  4. Kojima-Yuasa and Matsui-Yuasa, "Pharmacological effects of 1'-acetoxychavicol acetate, a major constituent in the rhizomes of Alpinia galanga and Alpinia conchigera," Journal of Medicinal Food, 2020 — includes the antimicrobial literature on ACA. Find on PubMed.
  5. Live search: Alpinia galanga, antifungal activity and dermatophytes — the in-vitro basis for the ringworm tradition.
  6. Live search: 1'-Acetoxychavicol acetate and Candida albicans — including work on azole-resistant isolates.
  7. Live search: Alpinia galanga essential oil, antibacterial activity — the membrane-disruption literature.
  8. Live search: Galangal and Staphylococcus aureus — a commonly screened target organism.
  9. Live search: Spice extracts and antimicrobial food preservation — the setting where in-vitro data legitimately applies.
  10. Live search: Plasmid curing and antibiotic resistance — the wider field the ACA result belongs to, and its translational track record.
  11. Live search: Galangal antibacterial activity alongside cytotoxicity — the selectivity question that decides whether activity is useful.

Safety and Disclaimer

Galangal is safe as a food. Applying fresh rhizome or extracts to skin can irritate or sensitise and should be patch-tested first, avoided on broken skin, and stopped if the area worsens. Galangal essential oil should never be swallowed. Concentrated extracts are unstudied in humans, may interact with anticoagulants, antiplatelet drugs and medications cleared by cytochrome P450 enzymes, and should be avoided in pregnancy and breastfeeding and not given to children. Nothing in this article supports using galangal in place of an antibiotic or antifungal. This page is educational, is not medical advice, and must not be used to delay assessment of an infection that is spreading, painful, feverish, or failing to improve.

Connections

Back to Table of Contents